DEXCOM ALERT: Bragar Eagel & Squire, P.C. is Investigating DexCom, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against DexCom, Inc. regarding a class action complaint filed due to alleged breaches of fiduciary duties by the board of directors [1] Financial Performance - On July 25, 2024, DexCom announced its Q2 fiscal 2024 financial results and reduced its revenue guidance for the full fiscal year 2024, attributing the results to the execution of several key strategic initiatives that did not meet their standards [2] - Following the announcement, DexCom's stock price plummeted from $107.85 per share on July 25, 2024, to $64.00 per share on July 26, 2024, marking a decline of approximately 40.66% in just one day [2]